Zomedica Corp.
ZOM was delisted on the 4th of March, 2025.
99 hedge funds and large institutions have $12.4M invested in Zomedica Corp. in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 9 closing their positions.
78% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 9
8% more funds holding
Funds holding: 92 → 99 (+7)
30% less capital invested
Capital invested by funds: $17.8M → $12.4M (-$5.37M)
38% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Atom Investors
Austin,
Texas
|
+$168K |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$38.6K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$34.3K |
| 4 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$33.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$30.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ProShare Advisors
Bethesda,
Maryland
|
-$515K |
| 2 |
CCM
Connective Capital Management
Palo Alto,
California
|
-$240K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$80.7K |
| 4 |
BlackRock
New York
|
-$73.8K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$71.6K |
ZOM Hedge Fund Activity: Q1 2024 in Review
99 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q1 2024, worth a combined $12.4M — down 30% from $17.8M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new ZOM positions and 9 closed out — a net gain of 7 holders — while 13 added to existing stakes and 21 trimmed.
The largest buyer was Atom Investors, opening a new position worth an estimated $168K. The largest seller was ProShare Advisors, exiting entirely with an estimated $515K sold.
- 99 institutional investors held Zomedica Corp. (ZOM) as of Q1 2024, up from 92 in Q4 2023.
- Funds reported $12.4M of Zomedica Corp. stock for Q1 2024, down 30% quarter-over-quarter.
- 16 funds opened new Zomedica Corp. positions in Q1 2024 and 9 closed out, a net change of +7 holders.
- The largest Zomedica Corp. buyer in Q1 2024 was Atom Investors, an estimated $168K added.
- The largest Zomedica Corp. seller in Q1 2024 was ProShare Advisors, an estimated $515K sold.
Based on aggregated 13F filings for Q1 2024.